Warby Parker Inc(WRBY) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 413.01 | EPS (ttm) | 0.06 | Insider Own | 17.33% | Shs Outstand | 107.7M | Perf Week | -2.15% |
| Market Cap | 3.10B | Forward P/E | 40.42 | EPS next Y | 47.8% | Insider Trans | -3.6% | Shs Float | 102.2M | Perf Month | 1.66% |
| Enterprise Value | 3.06B | PEG | 1.02 | EPS next Q | 0.09 | Inst Own | 101.15% | Short Float | 20.07% | Perf Quarter | -3.69% |
| Income | 0.01B | P/S | 3.4 | EPS this Y | 16.71% | Inst Trans | 16.87% | Short Ratio | 7.15 | Perf Half Y | 11.27% |
| Sales | 0.91B | P/B | 7.89 | EPS next 5Y | 39.62% | ROA | 1.05% | Short Interest | 20.50M | Perf YTD | 15.05% |
| Book/sh | 3.18 | P/C | 10.59 | EPS past 3/5Y | - | ROE | 2.06% | 52W High | -19.13% ($31.00) | Perf Year | 16.6% |
| Cash/sh | 2.37 | P/FCF | 142.48 | Sales past 3/5Y | 13.39% 17.23% | ROIC | 1.27% | 52W Low | 67.58% ($14.96) | Perf 3Y | 94.64% |
| Dividend Est. | - | EV/EBITDA | 51.21 | EPS Y/Y TTM | 182.39% | Gross Margin | 52.61% | Volatility(W/M) | 5.19% 5.52% | Perf 5Y | -54.71% |
| Dividend TTM | - | EV/Sales | 3.35 | Sales Y/Y TTM | 10.99% | Oper. Margin | 0.25% | ATR (14) | 1.42 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.93 | EPS Q/Q | 358.04% | Profit Margin | 0.85% | RSI (14) | 48.11 | Recom | 1.64 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.18 | Sales Q/Q | 9.81% | SMA20 | -2.5% ($25.71) | Beta | 1.95 | Target Price | $31 |
| Payout | - | Debt/Eq | 0.64 | Earnings | 2026/11/5 | SMA50 | -0.9% ($25.3) | Rel Volume | 0.7 | Prev Close | $25.28 |
| Employees | 4036 | LT Debt/Eq | 0.55 | EPS/Sales Surpr. | 63.82% -1.04% | SMA200 | -0.58% ($25.22) | Avg Volume(3M) | 2.87M | Price | $25.07 |
| IPO | 2021/9/29 | Option/Short | Yes/Yes | Trades | 12959 | Volume | 1,998,894 | Change | -0.83% |
👓 This is an American eyewear company that sells glasses and eyewear products. It designs and sells its own eyewear and contact lenses, as well as offering vision exams both online and in stores, and is known for its vertically integrated business model and affordable pricing. It operates in the eyewear industry.
Over the past 1 year, roughly in the middle
19% below its 1-year high.
Traded less than usual. That is 70% of its average volume.
Next earnings report: November 5
8 days to go.
WRBY earns at a steady pace
Of every $100 in sales, $0.25 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +16.7% this year.
Tap to view numbers
However, it looks expensive
Counting its debt, for $100 of yearly operating cash you would pay $5,121. Peers typically go for $1,598. Compared with its own 1-year average, it is 79% cheaper now.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -54.7%. The S&P 500 did +70% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Short interest is a burden
20.1% of the float is sold short.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #23 of 51 in the industry
Based on market cap of $3B.
ICUI#19 ICU Medical Inc $4B PER 137.9 
PLSE#20 Pulse Biosciences Inc $4B PER - 
NVST#21 Envista Holdings Corp $4B PER 41.0 
ATRC#22 Atricure Inc $3B PER 284.1 WRBY#23 Warby Parker Inc $3B PER 413.0 
FAQ
What kind of company is WRBY?
WRBY belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of WRBY?
The market cap of WRBY is approximately $3.1B, ranking 1,737 within its sector.
What is the P/E ratio of WRBY?
WRBY has a P/E ratio of approximately 413.0x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for WRBY?
WRBY has recorded a 52-week high of $31.00 and a low of $14.96.
